Journal
MOLECULAR MEDICINE REPORTS
Volume 15, Issue 5, Pages 2925-2930Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/mmr.2017.6419
Keywords
penetrating peptide; mechanism; application; cancer treatment; diagnosis
Categories
Funding
- Nature Science Foundation of China [81301946]
- China Postdoctoral Science Foundation [2013M540467, 53470135]
- Nature Science Foundation of Jiangsu Province [BK2012146]
- Jiangsu Provincial Office of Education Foundation [JHB2012-34]
Ask authors/readers for more resources
As a tumor-targeting and -penetrating peptide, iRGD binds to alpha v integrins and neuropilin-1 receptors, which are expressed at high levels on tumor cells and the surfaces of vasculature. Subsequently, iRGD penetrates deep into the tumor parenchyma with antitumor drugs, imaging agents, immune modulators and biological products. These substances are either chemically linked to the peptide or co-injected with the peptide. The iRGD peptide can be readily synthesized, exhibits significantly improved penetration, compared with traditional peptides, and can effectively inhibit tumor metastasis. Therefore, the peptide is now used widely for the diagnosis and treatment of cancer. However, whether the peptide is able to promote the entry of drugs into non-targeted cells remains to be fully elucidated. In this review, an overview of iRGD is presented, focusing on its identification, mechanism of action and previous studies on its roles in various types of cancer. Studies in previous years have demonstrated the potential of the iRGD protein for tumors diagnosis and targeted treatment, which warrants further investigation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available